EXAONE Path 2.0 Next-Generation Precision Medical AI Debuts
LG AI Research has launched EXAONE Path 2.0, a cutting-edge precision medical AI model that predicts gene mutations and biological markers.
Read MorePosted by Chris Wolski | Jul 11, 2025 | Lab Automation |
LG AI Research has launched EXAONE Path 2.0, a cutting-edge precision medical AI model that predicts gene mutations and biological markers.
Read MorePosted by Chris Wolski | Jul 11, 2025 | Lung Cancer |
New multidisciplinary guidelines bronchoscopic lung biopsy techniques offer tissue sampling adequacy comparable to other testing methods.
Read MorePosted by Chris Wolski | Jul 9, 2025 | Colorectal |
Personalis has expanded and extended its partnership with Tempus AI to include colorectal cancer in their NeXT Personal MRD test.
Read MorePosted by Chris Wolski | Jul 7, 2025 | Sequencing Systems |
The FDA has approved Thermo Fisher’s Oncomine Dx Express Test on the Genexus Dx Integrated Sequencer as a companion diagnostic for ZEGFROVY.
Read MorePosted by Chris Wolski | Jun 18, 2025 | Cancer |
Researchers have developed an AI blood test called Fragle to accurately and affordably track cancer treatment response and detect relapse.
Read More